Latest News

United States Antimony (UAMY) has stepped into the spotlight after back to back appearances at the BMO Global Metals, Mining & Critical Minerals Conference and PDAC 2026, supported by fresh investor materials on its integrated North American platform. See our latest analysis for United States Antimony. The recent conference appearances and supply chain updates come against a backdrop of strong momentum, with a 90 day share price return close to 99% and a very large 1 year total shareholder...

LXP Industrial Trust (LXP) has put fresh numbers in front of investors with its Q4 2025 investor presentation, spotlighting 97.1% portfolio occupancy and a new approximately 1 million square foot Phoenix development tied to strong industrial demand. See our latest analysis for LXP Industrial Trust. At a share price of $49.09, LXP Industrial Trust has seen a 15.53% 1 year total shareholder return, even though its year to date share price return is slightly negative and short term moves remain...

Sea Limited recently confirmed it would release its fourth quarter 2025 results and host its earnings call on March 3, 2026, at 9:30 a.m. US Eastern Standard Time. This upcoming update follows a period where investors have become more focused on a projected slowdown in Sea’s revenue growth momentum. We’ll now examine how expectations for slower year-on-year revenue growth heading into this earnings release may influence Sea’s investment narrative. Uncover the next big thing with 30 elite...

BigBear.ai Holdings (BBAI) has caught investor attention after recent trading, with the share price closing at US$4.10 and short term returns showing sharp moves over the past month and over the past 3 months. See our latest analysis for BigBear.ai Holdings. Those recent sharp short term share price moves sit against a tougher backdrop, with a 30 day share price return of 18.65% and a 90 day return of 29.19%, while the 1 year total shareholder return of 13.87% contrasts with a 3 year total...

If you are wondering whether Alignment Healthcare is attractively priced at its current level, this article will walk through how the market might be valuing the stock today and what that could mean for you. The share price closed at US$19.65 recently, with returns of a 1.3% decline over the last week, a 12.8% decline over the last month, a 2.8% decline year to date, and a 26.6% gain over the past year, as well as a very large gain over three years. These moves have come alongside ongoing...

Why Schneider National Stock Is Getting Attention Now With no single headline event setting the tone, Schneider National (SNDR) is drawing interest as investors weigh its recent share performance, profitability metrics, and scale across truckload, intermodal, and logistics operations. See our latest analysis for Schneider National. Schneider National’s recent share price has been relatively firm at US$28.16, with a 20.14% 90 day share price return and a 9.73% 1 year total shareholder return...

Datadog (NasdaqGS:DDOG) has entered a new partnership with Sakana AI focused on enterprise AI adoption and joint research. The collaboration targets large enterprises in Japan first, with an intention to extend offerings to global customers over time. Both companies plan to combine Datadog's cloud and monitoring capabilities with Sakana AI's scalable models for real world deployments. Datadog, trading at around $111.11, sits in an interesting spot for investors reviewing its recent...

Boeing (NYSE:BA) has secured major jet deals with Vietnamese airlines, including what has been described as the largest-ever wide-body order by a Vietnamese carrier. The company has also signed a significant single aisle aircraft agreement with Vietnam’s national airline. In 2025, Boeing reported more plane orders than Airbus for the first time in seven years. These developments follow efforts to address production issues and strengthen quality controls. Boeing is a global aerospace...

Nexa Resources S.A. reported a turnaround in its 2025 results, with sales of US$3,002.06 million, net income of US$132.63 million, a US$12.5 million impairment on long-lived assets, and a proposed dividend of about US$17.5 million (US$0.132136 per share) for payment in August 2026, subject to AGM approval. The company’s return to profitability alongside a proposed cash dividend, while reaffirming 2026 production guidance after only minimal disruption at the Atacocha mine, highlights...

SoundHound AI (NasdaqGM:SOUN) introduced its new Sales Assist voice-powered retail agent at Mobile World Congress 2026. The company launched a new innovation hub in Bengaluru, India, to expand its global AI development capabilities. Sales Assist is aimed at frontline retail environments, focusing on real-time prompts, recommendations, and workflow support. SoundHound AI (NasdaqGM:SOUN) is best known for its voice and conversational AI in areas like automotive and restaurants, and this move...

Centuri Holdings (CTRI) has turned heads after reporting record 2025 revenue, a sharply higher year end backlog of about $5.9b, and issuing 2026 guidance that points to higher revenue and profit targets. See our latest analysis for Centuri Holdings. That record 2025 result and larger backlog have come after a strong run in the share price, with a 30 day share price return of 12.10% and a 90 day return of 26.49%. The 1 year total shareholder return of 92.17% suggests momentum has been...

Cogent Communications Holdings recently reported fourth-quarter 2025 and full-year results showing a reduced net loss of US$30.78 million for the quarter and US$182.17 million for the year, and on February 18, 2026 its board approved a regular first-quarter 2026 dividend of US$0.02 per share payable March 20, 2026. The combination of narrowing losses and maintaining a cash dividend highlights management’s continued focus on shareholder distributions even while the business remains...

If you are wondering whether Saab's current share price still reflects good value, it helps to step back and look at what the market has been pricing into the stock. Over the past week Saab is roughly flat with a 0.1% return, has seen a 6.2% decline over the last month, yet sits on gains of 16.1% year to date and 83.1% over the past year, with a very large return over five years from a low base. These sharp longer term moves have kept Saab on many investors' watchlists, particularly as...

Limbach Holdings (LMB) is back in focus after reporting fourth quarter and full year 2025 results, with higher sales, net income and earnings per share compared with the prior year periods. See our latest analysis for Limbach Holdings. The latest earnings release comes after a strong run in the shares, with a 90 day share price return of 29.7% and a 1 year total shareholder return of 15.65%. The 3 year total shareholder return is around 7x, and recent weekly moves have cooled short term...

For investors wondering if Century Communities at around US$65.99 offers solid value, this article walks through what the numbers indicate about the stock today. The share price has seen mixed recent returns, with about a 5.7% decline over the last 7 days, a 4.8% gain over 30 days, around 12.0% year to date, and roughly a 1.0% decline over the past year. This combination can leave investors unsure how to interpret the risk and reward trade off. Recent coverage of homebuilders and housing...

If you are wondering whether Abbott Laboratories at about US$114 per share is offering fair value right now, you are not alone. This article walks through how that price stacks up against a few different valuation yardsticks. The stock has seen mixed returns, with a 1% decline over the past week, a 4.4% gain over the last 30 days, and longer term moves of an 8.1% gain over 5 years but a 17.1% decline over the past year and an 8.1% decline year to date, which may signal shifting expectations...

Cytokinetics (NasdaqGS:CYTK) has secured regulatory approval from both the FDA and the European Commission for MYQORZO™, a treatment for obstructive hypertrophic cardiomyopathy (oHCM). MYQORZO™ is expected to reach patients in the U.S. and Europe with sales commencing in Q1 2026. The approvals open access to two major markets and introduce a new potential revenue source for Cytokinetics. Cytokinetics enters this phase with MYQORZO™ approved on both sides of the Atlantic and a current share...

If you are wondering whether American Financial Group at around US$134.50 is offering fair value or hiding a margin of safety, you are not alone. The stock closed at US$134.50 with returns of 3.8% over the past week, 3.2% over the past month, a slight year to date decline of 0.2%, and an 11.9% return over the past year, with 21.6% over three years and 96.8% over five years. Recent attention on American Financial Group has focused on its position as a specialist insurer and how investors are...

Domino's Pizza (DPZ) is back in focus after reporting detailed fourth quarter and full year 2025 results, pairing those figures with a double digit dividend increase and updates on store growth and share repurchases. See our latest analysis for Domino's Pizza. The recent earnings release, dividend increase and update on buybacks come against a softer share price backdrop, with a 90 day share price return of a 5.48% decline and a 1 year total shareholder return of a 15.72% decline, hinting...

Recent performance snapshot THOR Industries (THO) has drawn investor attention after a stretch of weaker returns, with the stock down about 11% over the past week and about 14% over the past month. That share performance sits against annual revenue of roughly US$9.83b and net income of about US$282 million. This gives investors a current reference point as they think about the recreational vehicle maker’s valuation and prospects. See our latest analysis for THOR Industries. At around US$95.69...

Kimbell Royalty Partners, LP reported past fourth-quarter 2025 results showing revenue of US$82.45 million and net income of US$21.83 million, alongside full-year 2025 revenue of US$333.83 million and net income of US$90.95 million, and declared a Q4 2025 cash distribution of US$0.37 per common unit. The partnership also issued 2026 production guidance of 24.0–27.0 Mboe/d with a balanced mix of oil, natural gas, and NGLs, while highlighting a US$230 million Midland Basin acquisition and the...

Why ZEISS Collaborative Care matters for Carl Zeiss Meditec shareholders Carl Zeiss Meditec (XTRA:AFX) has introduced ZEISS Collaborative Care, a browser-based tool for secure data sharing and referrals between eye care providers. This launch underscores the group’s push into connected digital workflows in ophthalmology. See our latest analysis for Carl Zeiss Meditec. Despite the ZEISS Collaborative Care announcement, Carl Zeiss Meditec’s recent trading has been weak. The company has reported...

Cameco has entered a long-term agreement to supply nearly 22 million pounds of uranium ore concentrate to India’s Department of Atomic Energy between 2027 and 2035 on market-related terms, reinforcing bilateral cooperation on critical minerals and energy that Canada and India recently expanded through a series of accords. This multi-year contract deepens Cameco’s role in fueling India’s nuclear reactor fleet, adding visibility to future uranium volumes while aligning with the company’s...

Eli Lilly (NYSE:LLY) and Scribe Therapeutics reached a key milestone in their collaboration to develop in vivo CRISPR-based genetic medicines targeting neurological and neuromuscular disorders. The European Medicines Agency issued a positive opinion for Olumiant in adolescents with severe alopecia areata, supporting a potential expanded indication in Europe. Detailed Phase 3 clinical trial results for orforglipron, Eli Lilly’s oral GLP-1 for weight management and diabetes, were released...